Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000360312

Medchemexpress LLC Remogliflozin etabonate | 442201-24-3 | 99.6% | 522.59 | 50 MG
SDP

Catalog No. 5000360312
Encompass_Preferred

Remogliflozin etabonate is an orally active, selective, and low-affinity sodium glucose cotransporter (SGLT2) inhibitor. It acts as a proagent, based on benzylpyrazole glucoside, and is metabolized in the body to its active form, Remogliflozin. This compound has demonstrated antidiabetic efficacy in rodent models.

  • Orally active and selective SGLT2 inhibitor
  • Metabolized to active form, Remogliflozin
  • Demonstrates antidiabetic efficacy in rodent models
  • Ki values for hSGLT2, rSGLT2, hSGLT1, and rSGLT1

Catalog No. 50-003-60312 Supplier Medchemexpress LLC Supplier No. HY1494550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Remogliflozin etabonate is an orally active, selective, and low-affinity sodium glucose cotransporter (SGLT2) inhibitor. It acts as a proagent, based on benzylpyrazole glucoside, and is metabolized in the body to its active form, Remogliflozin. This compound has demonstrated antidiabetic efficacy in rodent models.

  • Orally active and selective SGLT2 inhibitor
  • Metabolized to active form, Remogliflozin
  • Demonstrates antidiabetic efficacy in rodent models
  • Ki values for hSGLT2, rSGLT2, hSGLT1, and rSGLT1

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.